News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Analyst action
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Viemed Healthcare's recent earnings, despite seemingly weak stock performance, are better than they appear due to strong cash conversion. The company recorded a negative accrual ratio of -0.11, indicating its free cash flow of US$29m significantly exceeded its statutory profit of US$14.5m. Additionally, unusual …
Freedom Capital downgraded Viemed Healthcare (NASDAQ:VMD) from a "strong buy" to a "hold" rating, while Weiss Ratings simultaneously upgraded it to a "buy." Despite the conflicting ratings, MarketBeat's consensus remains "Hold." The company recently reported Q2 EPS of $0.07, missing analyst estimates, but revenue …
This article announces a Form 144 filing by Viemed Healthcare, indicating a proposed sale of securities. The notice is made pursuant to Rule 144 of the Securities Act of 1933, which permits the public resale of restricted and controlled securities if certain conditions are …
Viemed Healthcare's stock (VMD) dropped almost 16% despite increased Q2 2026 revenue, as net income and profit margins declined year-over-year. The market is reacting to margin pressure, with trailing net profit margin falling to 4.8% from 5.8%, raising questions about whether diversification efforts are …
Arrowstreet Capital Limited Partnership significantly increased its stake in Viemed Healthcare (NASDAQ:VMD) by 101.9% in the first quarter, now owning 1.85% of the company. Other institutional investors like Invesco and Martingale Asset Management also boosted their holdings. Despite beating revenue estimates, Viemed Healthcare missed …
This page provides a comprehensive overview of Viemed Healthcare, Inc. (VMD) stock, including its current price, recent news headlines, and historical performance data. The stock closed at $9.73 on August 7 and has shown positive year-to-date and one-year returns, outperforming the S&P 500 in …
Viemed Healthcare reported mixed Q2 2026 results, with revenue slightly exceeding estimates but earnings falling short, causing a 17% stock drop. The company achieved record revenue of $78.1 million and its highest-ever active ventilator patients, driven by growth across its ventilator, sleep, resupply, and …
Viemed Healthcare (NASDAQ:VMD) reported Q2 2026 diluted earnings of $0.07 per share, significantly missing the $0.12 consensus estimate by 41.7%. Despite this, the company saw strong revenue growth, with $78.1 million representing a 23.9% increase year-over-year. The shortfall in earnings, alongside operational expansion serving …
Viemed Healthcare, Inc. announced record-setting Q2 2026 financial results, with net revenues of $78.1 million, a 23.9% increase year-over-year. The company also reported an increase in ventilator patients to 12,635 and PAP therapy patients to 37,825. Due to strong performance, Viemed has updated its …
Viemed Healthcare Inc (VMD) reported strong Q2 2026 financial results with net revenues of $78.1 million, a 23.9% increase year-over-year, and significant growth in patient numbers for ventilator and PAP therapy. Despite this growth, net income and Adjusted EBITDA saw declines, and the stock …
Viemed Healthcare, Inc. (VMD) reported Q2 earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.10. Despite this earnings miss, the company's revenues of $78.1 million surpassed estimates and showed growth from the prior year. The stock has outperformed the S&P 500 …
Lazard Asset Management LLC significantly increased its stake in Viemed Healthcare, Inc. (NASDAQ:VMD) during the first quarter, adding 116,700 shares to own 215,938 shares valued at approximately $1.99 million. Despite this, Viemed Healthcare reported quarterly earnings per share of $0.06, missing the consensus forecast …
Viemed Healthcare (VMD) reported a 23.9% increase in Q2 2026 revenue, reaching $78.1 million, driven by growth in ventilator rentals, other home medical equipment, and equipment and supply sales, including contributions from the Lehan Drugs acquisition. Despite the revenue growth, net income attributable to …
* Viemed Healthcare (VMD [https://seekingalpha.com/symbol/VMD]) is scheduled to announce Q2 earnings results on Tuesday, August 4th, before market open. * The consensus EPS Estimate is $0.12 [https://seekingalpha.com/symbol/VMD/earnings/estimates] and the consensus Revenue Estimate is $78M * Over the last 1 year, VMD has beaten EPS …
This article analyzes Viemed Healthcare Inc. (NYSE: VMD) using AI-generated quant signals. It identifies a neutral near and mid-term outlook with a long-term positive bias, noting a mid-channel oscillation pattern. The analysis presents specific trading strategies (Position, Momentum Breakout, Risk Hedging) with entry, target, …
The article focuses on the "Enterprise value to EBIT forward" metric for Viemed Healthcare, Inc. (NASDAQ: VMD). It is a financial data point presented on TradingView, indicating the company's valuation relative to its future earnings before interest and taxes.
Viemed Healthcare, Inc. (VMD) is expected to announce its Q2'26 earnings on August 3rd, with an estimated EPS of $0.12 and revenue of $78.00 million. This article provides a comparative table of reported and estimated revenue and EPS figures for recent quarters, highlighting surprises.
Viemed Healthcare Inc (VMD) currently holds a financial score of 8.51, ranking 14th out of 75 in the Healthcare Providers & Services industry, indicating robust financial health and high operating efficiency. The company's financials, including profitability, balance sheet, and cash flow, contribute to this …
Viemed Healthcare Inc (VMD) has a risk assessment score of 6.28, placing it 29th out of 75 in the Healthcare Providers & Services industry. Its beta of 1.13 suggests higher volatility compared to the S&P 500. The article details various risk metrics including maximum …
Viemed Healthcare (NASDAQ:VMD) is projected to release its Q2 2026 earnings after market close on Monday, August 3rd, with analysts anticipating $0.10 EPS and $78.00 million in revenue. The company's previous quarter missed EPS estimates but exceeded revenue expectations. Insider sales have been noted, …
The article discusses Viemed Healthcare Inc (VMD) and its revenue breakdown by business segments and regional revenue, along with profit contribution. However, it explicitly states that the relevant data for these breakdowns have not yet been disclosed by the company. The page provides basic …
This article provides a detailed quarterly and annual balance sheet analysis for Viemed Healthcare Inc (VMD). It allows users to evaluate the company's financial health, examine fundamentals, and calculate key liquidity, leverage, and return on equity ratios. The data includes various assets, liabilities, and …
Punch & Associates Investment Management Inc. reduced its stake in Viemed Healthcare, Inc. by 20% in the first quarter, selling 133,999 shares. Additionally, two company insiders, Director Timothy Smokoff and insider William Frazier, also sold shares of VMD stock. The company recently missed EPS …
Viemed Healthcare Inc (VMD) has an institutional confidence score of 7.00, placing it 37th out of 75 in the Healthcare Providers & Services industry. Institutional shareholding stands at 72.39%, showing an 8.13% quarter-over-quarter increase. First Eagle Investment is the largest institutional shareholder, holding 493.43K …
Forager Fund, L.P., Forager Capital Management, LLC, Edward Kissel, and Robert MacArthur have collectively disclosed a 4.9% beneficial ownership stake in Viemed Healthcare, Inc. (VMD) through an amended Schedule 13G filing. This group beneficially owns 1,886,872 shares, representing 4.9% of the 38,336,802 shares outstanding …
Viemed Healthcare Inc. (VMD) is trading at $11.77, up 0.86%, with a market cap of $453.54M. The company, an in-home clinical care provider of post-acute respiratory healthcare equipment and services, shows strong fundamentals and high growth potential, though its valuation is considered fairly valued. …
This article provides a brief mention of the "Price to sales forward" metric for Viemed Healthcare, Inc. (NASDAQ:VMD) within the context of TradingView's financial data offerings. While it lists the company, its stock symbol, and the market it trades on, specific financial figures or …
This article provides an AI-driven analysis of Viemed Healthcare Inc. (VMD), highlighting a near-term neutral sentiment amidst mid and long-term strength. It presents institutional trading strategies for VMD, including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis to guide potential investments. …
This article provides financial information for Viemed Healthcare, Inc. (SWB:VIJ) on TradingView, specifically focusing on its enterprise value to EBIT forward. It mentions the company's market status on the Stuttgart Stock Exchange and points to various financial data available on the platform.
Viemed Healthcare, Inc., a national provider of home-based healthcare solutions, has scheduled its Second Quarter 2026 Earnings Conference Call for August 4, 2026, at 11:00 a.m. EDT. The company will discuss its financial performance and operational results. Access details for the live broadcast and …
The article displays the "Price to earnings forward" metric for Viemed Healthcare, Inc. (SWB: VIJ) on the Stuttgart Stock Exchange. It indicates that the market was closed and no trades occurred, providing a snapshot of the company's financial data on TradingView. The content is …
Search by ticker symbol or company name and select a result to open its chart.